alkem

1
ALKEM LABORATORIES
Making Positive Difference To Lives Across The
Globe
2
Vision
To achieve value driven leadership in Indian
Health Care Industry and beyond through
Quality that is infinite Service that
cares Hardwork that endures.
3
Goal
To be one of the Top 3 Companies in India and
also be a successful global Company through
innovations and strategic alliances
4
Visionary Founder and Chairman
5
Managing Director
6
4 Decades Of Giant Strides

• The Pharma Major since 1973

Turnover Rs 1,293 cr
Ranked No. 5 in the Indian Pharma Industry
Enjoys high respect from Medical profession
trade in India
Reputed for building mega brands
7
4 Decades Of Giant Strides
Buoyant organic growth due to excellent marketing
and sales
On the path of rapid globalisation
Products exported to 60 countries
moving ahead to become one of the top 3 Indian
companies
8
Sales Break Up Acute And Chronic Segments
7 Chronic Segment
93 Acute Segment
9
Total Sales Turnover
 Year 2005-06 2006-07 2007-08 2008-09 2009-10
Total Sales 169 226 239 272 318
Val in Mn US
10
2009 - 10 Domestic Sales
SBUs Value(in Crs)
692.95
150.91
95.73
13.79
111.08
21.72
27.75
15.05
29.70
6.82
Alkem Institution 6.34
Exports 121
Total (App.) 1293
Main Division
Bergen
Ulticare
Pentacare
Generic
Cytomed
Mediva
Derma Care
Alkem Pharma
Alkem Health Foods
11
Top 10 Domestic Company

• 1. CIPLA
• 2. RANBAXY
• 3. GLAXO SMITHKLINE
• 4. ZYDUS CADILLA
• 5. NICHOLAS PIRAMAL
• 6. SUN
• 7. PFIZER
• 8. ALKEM
• 9. MANKIND
• 10. LUPIN

12
Growth Rate of Company

• Mankind 37
• Pfizer 33
• Sun 26
• ALKEM 23
• Zydus Cadila 23
• Aristo 20
• Cipla - 18
• Glaxo Group - 17
• Lupin - 16
• Ranbaxy - 11

13
ALKEM -A Brand Building Company
Taxim (Cefotaxime) a flagship brand is among
the top 15 brands of Indian Pharmaceutical
Industry
11 other brands in the list of top 300 mega brands
No. 1 in Cephalosporins
Front runners in Co-AmoxyClav and Quinolone
segments
14
Brands In Top 300 Of Indian Pharma Market
Rank Val in Cr.
11 131.72
15 105.88
30 87.27
74 57.63
82 51.94
83 51.89
94 45.53
117 40.82
145 36.84
168 32.92
232 27.29
Taxim (Cefotaxime)
Taxim-O (Cefixime)
Clavam (Co-Amoxyclav)
Pan
Sumo ( NSAID)
Gemcal (Calcitrol)
A TO Z (Multi Vitamin/Anti-oxidants)
Xone (Ceftriaxone)
Pan - D
Ondem
Hemfer (Hematinic)
ORG Mat May 2010
15
ALKEM in Cephalosporins
Company Rank Value (in Cr.) MS Gr
Market 3185.96 17
ALKEM 1 396.85 12.5 7
Aristo 2 271.72 8.5 25
Ranbaxy 3 246.63 7.7 17
ORG Mat May 2010
16
ALKEM in Co-AmoxyClav
Company Rank Value (in Cr.) MS Gr
Market 634.07 35
Glaxo Smithkline 1 154.21 24.43 31
ALKEM 2 93.95 14.8 33
Mankind 3 70.27 11 20
ORG Mat May 2010
17
ALKEM in Quinolones
Company Rank Value (in Cr.) MS Gr.
Market 972.71 4
Ranbaxy 1 191.26 19.7 14
Cipla 2 146.58 15.11 7
Mankind 3 72.02 7.4 14
ALKEM 8 31.61 3.2 26
ORG Mat May 2010
18
Firsts From Alkem

• First Indian Company To Develop, Manufacture
  Market These Products In India
• Anaestrazole
• Cefotaxime Sulbactam
• Satranidazole
• Ceftriaxone Tazobactam
• Cefixime Clavulanic Acid

• First Company To Market These Products In
  India
• MEROPENAM
• CEFEPIME

19
Important New Products Launched

• Cefixime Clavulanic Acid
• Ceftriaxone Tazobactam
• Pantaprazole Itopride
• Aceclofenac Range
• Rabeprazole Diclofenac
• Meropenam
• Cefipime
• Piperacillin Tazobactam
• Cefotaxime Sulbactam

• Cefprozil
• Gatifloxacin
• Cefpodoxime Proxetil
• Rabeprazole
• Rabeprazole Domperidone
• Sodium Feredetate
• Donepezil

20
Important New Products Launched

• Levo Cetirizine
• Aripiprazole
• Bicalutamide
• Natural Micronised Progesterone
• Anaestrazole
• Paclitaxel
• NATURAL PRODUCTS
• Pycnogenol
• INTERESTING NUTRACEUTICAL PRODUCTS
• Protein Diskettes
• Meal Replacer Bars
• Nutraceutical soups

• Atorvastatin Ezetemibe
• Pioglitazone Metformin
• Metformin SR
• Glimepiride
• EsCitalopram
• Mirtazapine
• Quetiapine
• Nebivolol

21
Our Core Strengths
Focussed SBUs
Technical Expertise
People
Logistics
Finance
22

• Focussed SBUS

23
Focused SBUs
Main Pharma Division
Ulticare
Bergen
Pentacare
Mediva
Cytomed
Derma Care
24
Therapy Representation Of SBUs

• Main Pharma
• Anti-infective
• Gastroenterology
• Gynecology
• Pediatric
• Surgery
• Nutraceuticals
• Nsaids
• Urology

• Ulticare
• Anti-infective
• Nutraceuticals
• Anti-tuberculosis
• Special Focus - Paediatrics

• Bergen
• Anti-infective
• Orthopedics
• Nutraceuticals
• Dermatology

25
Therapy Representation Of SBUs
Dermacare Skin Care
Division

• Pentacare
• Anti-parkinson's
• Anti-depressants
• Anti-psychotics
• Anxiolytics
• Anti-epileptics
• Anti-alzheimer's

• Mediva
• Cardio Vascular Anti Diabetic Range

• Cytomed
• Anti-cancer
• Anti retrovirals

26
Diversified Business

• Alkem Health Foods
• Jeevan prash a tasty, Low Calorie sugar free
  chyawanprash
• Blocal Low Calorie Sweetner
• Tammy
• Salt Substitute, Fat Substitutes and Sucralose
  based products Jams, Cookies, Jelly, Juices
  cakes (Calorie Conscious and Diabetics),
  Cholesterol free edible Oil.

27

• Technical Expertise

28
The Research And Development Centre Active In
Almost All Facets Of The Business

• RD centre at Mumbai approved by DSIR
• Formulation development for domestic market
• Formulation development for MAA/ANDA program
• Process development group for APIs and
  nutraceuticals
• Fully equipped modern state-of-the-art labs
• Sophisticated information services

29
(No Transcript)
30
(No Transcript)
31
State-of-the Art Manufacturing Committed To
International Quality Compliance

• 7 World class manufacturing facilities
• 2000 Million units of Tablets per annum
• 200 Million units of Capsules p.a
• 500 Million units of Injectable p.a
• 60 Million units of Liquids p.a
• 600 Million units of dry syrups p.a
• 30 Mn Units of I.V. infusions p.a.

32
Manufacturing Locations

• Daman Amailya and Kachigam Plant
• Gujrat -Mandava and Ankaleshwar Plant
• Himachal Pradesh Baddi
• Sikkim - Rangpo

33
(No Transcript)
34
Contract Research Organization( Phoenix
Bio-Pharma Research Centre )

• Conforming to International standards
• Bio- equivalence studies
• Drug Metabolism Pharmacokinetics
• Method Development / Method Validation etc.
• Post Marketing Surveillance
• Independent Ethics Committee comprising of well
  known personalities eg. Dr. H.P. Tipnis
• Low cost for studies as compared to the west

35
(No Transcript)
36

• People

37
ALKEM Our People
Over 6000 employees

• Cohesive team of professionals with a proven
  track record and complementary skills
• Well Trained, Competent and Dedicated field force
  across the country
• Creative Vibrant strategic Marketing Team with
  experience of building mega brands
• Competent pool of Scientists, Pharmacists
  Technologists

38
Our Values

• Honesty and Integrity
• Respect/care concern for people
• Customer Orientation
• Commitment to Quality
• Learning Organization
• Dedication and Commitment
• Trust
• Teamwork
• Openness and Transparency
• Discipline
• Result Oriented

39

• Logistics

40
Selling Distribution Channels

• Depots 24
• CF 4
• Warehouse 4
• 3000 Field Force spanning the entire country
• 1,40,000 retailer coverage
• 3,65,000 Doctor coverage ( 40 of universe )

41

• Finance

42
Financial Strength

• Negligible Debt Major Project Cost and Expansion
  Programs met out of Retained Earnings
• Low Borrowing Cost, Interest Cost progressively
  becoming nil, Net Income generated on the
  Interest Front
• Owns substantial Properties and Tangible Assets
• Tax Planning, Profit Tax free subject to MAT
• Liquidity
• Accumulated Cash Reserves and Surplus
• Surplus available for Expansion, RD and MA
  Activity

43

• International Footprint

44
Key Attributes
Excellent growth in exports in last 3 years
  Currently exports to more than 60
countries Exports to regulated markets in Europe
including UK
45
Strategic Approach

• 1.   Marketing through agent network in
  Unregulated and Semiregulated
  markets
• 2.  Regulated Markets
• Toll manufacture for large generic companies in
  Highly regulated markets like Europe, South
  Africa, Australia USA
• Own European filings US ANDAs
• Strategic Alliances , Acquisitions JVs

46
Strategic Alliance

• Contract manufacturing for generic companies in
• regulated European Market
• Alliance with other European and American generic
  
• majors in process
• Tie-up for innovative nutraceuticals and food
  products in
• process

47
REGULATORY APPROVALS

• Cephalosporin Block Oral Injectable (Daman)
• Approved by UK MHRA ( orals injectable )
• Approved by MCC, south Africa ( orals
  injectable )
• Approved by ANVISA, brazil (injectable)
•  Beta lactam block (daman)
• Approved by ANVISA brazil (injectables )
• Successfully inspected by UKMHRA ( Oral
  Injectable)
• approval expected shortly
• General block facility (daman)
• Approved by USFDA UKMHRA( ORAL ) and also
  approved by ANVISA Brazil
• USFDA Process for all the three Blocks has been
  initialized and completed

48

• Our New Ventures

49
Sucralose

• Developed a cost effective , environment
  friendly,
• patent non infringing process
• Confirms to USP-NF specifications
• Certified by CFTRI BAJAJ centre
• Dedicated facility based on regulated market
  requirements
• Capacity 10 tonnes/month

50
Foray Into Biotechnology

• First Phase HUMAN INSULIN
• EPO
• GCSF INTERFERO
• (GERMAN ASSOCIATION)

51
Looking Ahead

• MAAs in European Market
• ANDAs in USA
• Contract manufacturing for generic companies in
  regulated European Market
• In licensing arrangement for marketing PATENTED
  molecules in India
• Strategic alliances, Acquisitions JVs
• Backward integration to API manufacturing.
• cGMP lab pilot plant futuristic contract
  research business opportunities
• Identifying and Contract research business
  opportunities

52
Why you should work with Alkem

• We are Growing organization
• Fast Career Growth
• Performance Driven Organization.
• We are growing at the rate of 23 per annum as
  compared to the Industry growth rate of 17 .
• Compare to all top rank companies in domestic we
  are growing at higher rate.
• Incentive driven compensation structure.
• Believe in Fun at work place.

53
Web Site

• www. alkemlabs.com

54
Thank You !